Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $1,837 - $2,102
10 Added 0.64%
1,569 $329,000
Q1 2023

May 10, 2023

BUY
$191.89 - $259.92 $16,118 - $21,833
84 Added 5.69%
1,559 $314,000
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $1,773 - $2,250
-9 Reduced 0.61%
1,475 $321,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $270,740 - $371,801
1,484 New
1,484 $292,000
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $217,439 - $308,155
-851 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$351.38 - $448.68 $6,324 - $8,076
18 Added 2.16%
851 $321,000
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $127,070 - $156,280
-341 Reduced 29.05%
833 $344,000
Q1 2021

May 07, 2021

BUY
$249.67 - $299.48 $2,746 - $3,294
11 Added 0.95%
1,174 $340,000
Q4 2020

Feb 03, 2021

SELL
$222.0 - $252.62 $7,770 - $8,841
-35 Reduced 2.92%
1,163 $291,000
Q3 2020

Nov 04, 2020

SELL
$175.56 - $226.45 $100,595 - $129,755
-573 Reduced 32.35%
1,198 $271,000
Q2 2020

Aug 05, 2020

SELL
$118.84 - $189.72 $23,649 - $37,754
-199 Reduced 10.1%
1,771 $309,000
Q1 2020

May 06, 2020

BUY
$98.9 - $178.34 $194,833 - $351,329
1,970 New
1,970 $249,000
Q3 2019

Nov 04, 2019

SELL
$125.07 - $143.67 $340,690 - $391,357
-2,724 Closed
0 $0
Q2 2019

Aug 07, 2019

SELL
$123.4 - $148.55 $17,769 - $21,391
-144 Reduced 5.02%
2,724 $387,000
Q1 2019

May 01, 2019

SELL
$104.82 - $146.73 $150,521 - $210,704
-1,436 Reduced 33.36%
2,868 $417,000
Q2 2018

Jul 25, 2018

BUY
$102.37 - $117.25 $440,600 - $504,644
4,304 New
4,304 $471,000
Q1 2018

May 01, 2018

SELL
$98.19 - $115.2 $422,609 - $495,820
-4,304 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$96.72 - $109.26 $416,282 - $470,255
4,304
4,304 $465,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.33B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.